[go: up one dir, main page]

GB9904932D0 - Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy - Google Patents

Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy

Info

Publication number
GB9904932D0
GB9904932D0 GBGB9904932.2A GB9904932A GB9904932D0 GB 9904932 D0 GB9904932 D0 GB 9904932D0 GB 9904932 A GB9904932 A GB 9904932A GB 9904932 D0 GB9904932 D0 GB 9904932D0
Authority
GB
United Kingdom
Prior art keywords
chemotherapy
severity
preventing
reducing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9904932.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9904932.2A priority Critical patent/GB9904932D0/en
Publication of GB9904932D0 publication Critical patent/GB9904932D0/en
Priority to PCT/US2000/005186 priority patent/WO2000078299A2/en
Priority to JP2001504363A priority patent/JP2003502362A/en
Priority to AU79811/00A priority patent/AU7981100A/en
Priority to EP00970426A priority patent/EP1177016A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9904932.2A 1999-03-04 1999-03-04 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy Ceased GB9904932D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9904932.2A GB9904932D0 (en) 1999-03-04 1999-03-04 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
PCT/US2000/005186 WO2000078299A2 (en) 1999-03-04 2000-03-01 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
JP2001504363A JP2003502362A (en) 1999-03-04 2000-03-01 Compositions and methods for preventing / reducing the severity of side effects of chemotherapy and / or radiation therapy
AU79811/00A AU7981100A (en) 1999-03-04 2000-03-01 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
EP00970426A EP1177016A2 (en) 1999-03-04 2000-03-01 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9904932.2A GB9904932D0 (en) 1999-03-04 1999-03-04 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy

Publications (1)

Publication Number Publication Date
GB9904932D0 true GB9904932D0 (en) 1999-04-28

Family

ID=10848914

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9904932.2A Ceased GB9904932D0 (en) 1999-03-04 1999-03-04 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy

Country Status (5)

Country Link
EP (1) EP1177016A2 (en)
JP (1) JP2003502362A (en)
AU (1) AU7981100A (en)
GB (1) GB9904932D0 (en)
WO (1) WO2000078299A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
CA2399274A1 (en) 2000-02-07 2001-08-09 Mark E. Salvati 3-aminopyrazole inhibitors of cyclin dependent kinases
US6534531B2 (en) * 2000-04-27 2003-03-18 Bristol-Myers Squibb Company Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
WO2004041268A1 (en) * 2002-11-06 2004-05-21 Cyclacel Limited Combination comprising docetaxel and a cdk inhibitor
PT1940839E (en) 2005-10-07 2013-10-10 Exelixis Inc Pyridopyrimidinone inhibitors of pi3kalpha
HRP20110621T2 (en) 2006-09-15 2013-12-06 Pfizer Products Inc. PIRIDO [2,3-d] PIRIMIDINONE COMPOUNDS AND THEIR USE AS PI3 INHIBITORS
KR101432171B1 (en) 2013-01-22 2014-08-22 한국원자력의학원 Composition for diagnosis of radio-resistance or radio-sensitive CDK11A marker and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729545B2 (en) * 1994-10-24 2001-02-01 Baylor College Of Medicine Senescent cell-derived inhibitors of DNA synthesis
US5672508A (en) * 1996-01-23 1997-09-30 Mitotix, Inc. Inhibitors of cell-cycle progression, and uses related thereto
CA2289102A1 (en) * 1997-05-07 1998-11-12 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
GB9716557D0 (en) * 1997-08-06 1997-10-08 Glaxo Group Ltd Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
DE19816624A1 (en) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals

Also Published As

Publication number Publication date
AU7981100A (en) 2001-01-09
WO2000078299A3 (en) 2001-10-18
EP1177016A2 (en) 2002-02-06
WO2000078299A2 (en) 2000-12-28
JP2003502362A (en) 2003-01-21

Similar Documents

Publication Publication Date Title
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
HUP0202363A3 (en) Medicament useful for treating and/or suppressing weight gain
IL142906A0 (en) Methods and compositions for treating or preventing peripheral neuropathies
AU6528800A (en) Methods and apparatuses for radiation treatment
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
IL148803A0 (en) Novel composition and method for stabilizing the same
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
AU4136901A (en) Novel methods for the treatment and prevention of dizziness and pruritus
AU7360000A (en) Methods and compositions for preventing and treating prostate disorders
AU2476200A (en) Ribozyme therapy for the treatment and/or prevention of restenosis
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
AU6003999A (en) Cathodic protection method and device for metal structure
GB9904932D0 (en) Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL141426A0 (en) Compositions and methods for the treatment of tumor
AU7363000A (en) Method for reducing the risk of cancer
HUP0102995A3 (en) Agents and method for the protective treatment of wood
AU5338199A (en) Methods and compositions for inhibiting or stimulating telomerase assembly
PL352681A1 (en) Preventive and therapeutic agents for cancer
HUP9900436A3 (en) Installation and method for the treatment of wine-production efilvents
AU1792200A (en) Use of phanquinone for the treatment or prevention of memory impairment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)